Published on
Grant awarded to CHOP and Gustave Roussy to support phase 3 clinical trial developed by Children’s Oncology Group and International Society of Paediatric Oncology Europe Neuroblastoma Group, representing first-ever collaboration between North American and European neuroblastoma consortia.
Published on
A new study involving CHOP researchers looked at genetic variants across the genome to determine risk levels for developing schizophrenia in patients with 22q11.2DS.
Published on
A randomized controlled trial by CHOP researchers found that changing a tracheostomy tube at four days rather than seven is safe, with fewer complications.
Published on
John M. Flynn, MD, Chief of CHOP’s Division of Orthopaedics, elected Vice President of American Board of Orthopaedic Surgery.
Published on
Integrating 3D genomics with publicly available, genome-wide genetic data, CHOP researchers uncovered genetic correlations between IBD, stress, and depression.
Published on
Improved screening practices could decrease disparities by increasing referrals for developmental delays in traditionally underserved communities.
Published on
The GIANT Company donates $100,000 to support hospital’s efforts in addressing food insecurity during COVID-19 pandemic.
Published on
In a special segment broadcast in Panama in September, Diva D. De León-Crutchlow, MD, MSCE, recalled her path from her home county to her role as Chief of the Division of Endocrinology and Diabetes and Director of the Congenital Hyperinsulinism Center at Children's Hospital of Philadelphia (CHOP).
Published on
Improved and standardized variant curation guidelines will improve diagnostic accuracy for patients with mitochondrial disease evaluation.
Published on
2020 pandemic and subsequent revisions to state licensing procedures underscore how widespread adoption could keep drivers safe in challenging times while also improving evaluation.